Trial Profile
A Study to Evaluate the Efficacy and Toxicity of Belotecan in Treatment Naive Elderly Patients with Small Cell Lung Cancer (SCLC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Belotecan (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record